Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Stern

Showing results (191-200 of 243) with videos related to

Pageof 25
Sort By:
Cancer Research|November 20, 2002
Active signaling by HER-2/neu in a subpopulation of HER-2/neu-overexpressing ductal carcinoma in situ: clinicopathological correlatesMichael P DiGiovanna, Peiguo Chu, Tracey L Davison, et al.
American Journal of Industrial Medicine|July 1, 1995
Assessment of mortality in the construction industry in the United States, 1984-1986C Robinson, F Stern, W Halperin, et al.
Nature|December 6, 1984
The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigenA L Schechter, D F Stern, L Vaidyanathan, et al.
The New England Journal of Medicine|January 12, 2007
Release from prison--a high risk of death for former inmatesIngrid A Binswanger, Marc F Stern, Richard A Deyo, et al.
Nucleic Acids Research|January 12, 2012
Structural mechanism of the phosphorylation-dependent dimerization of the MDC1 forkhead-associated domainJinping Liu, Shukun Luo, Hongchang Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2000
Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancerA D Thor, S Liu, S Edgerton, et al.
Breast Cancer Research : BCR|November 21, 2008
ErbB3 is required for ductal morphogenesis in the mouse mammary glandAmy J Jackson-Fisher, Gary Bellinger, Jerrica L Breindel, et al.
Cancer Gene Therapy|June 11, 2011
DNA triplex-mediated inhibition of MET leads to cell death and tumor regression in hepatomaG Singhal, M Z Akhter, D F Stern, et al.
British Journal of Cancer|February 26, 2009
Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cellsS Agarwal, C Zerillo, J Kolmakova, et al.
Science Signaling|November 5, 2015
Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptakeJonathan W Haskins, Shannon Zhang, Robert E Means, et al.
Pageof 25

Showing results (191-200 of 243) with videos related to

Sort By:
Pageof 25
Cancer Research|November 20, 2002
Active signaling by HER-2/neu in a subpopulation of HER-2/neu-overexpressing ductal carcinoma in situ: clinicopathological correlatesMichael P DiGiovanna, Peiguo Chu, Tracey L Davison, et al.
American Journal of Industrial Medicine|July 1, 1995
Assessment of mortality in the construction industry in the United States, 1984-1986C Robinson, F Stern, W Halperin, et al.
Nature|December 6, 1984
The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigenA L Schechter, D F Stern, L Vaidyanathan, et al.
The New England Journal of Medicine|January 12, 2007
Release from prison--a high risk of death for former inmatesIngrid A Binswanger, Marc F Stern, Richard A Deyo, et al.
Nucleic Acids Research|January 12, 2012
Structural mechanism of the phosphorylation-dependent dimerization of the MDC1 forkhead-associated domainJinping Liu, Shukun Luo, Hongchang Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2000
Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancerA D Thor, S Liu, S Edgerton, et al.
Breast Cancer Research : BCR|November 21, 2008
ErbB3 is required for ductal morphogenesis in the mouse mammary glandAmy J Jackson-Fisher, Gary Bellinger, Jerrica L Breindel, et al.
Cancer Gene Therapy|June 11, 2011
DNA triplex-mediated inhibition of MET leads to cell death and tumor regression in hepatomaG Singhal, M Z Akhter, D F Stern, et al.
British Journal of Cancer|February 26, 2009
Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cellsS Agarwal, C Zerillo, J Kolmakova, et al.
Science Signaling|November 5, 2015
Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptakeJonathan W Haskins, Shannon Zhang, Robert E Means, et al.
Pageof 25